PUBLIC CONTRACT · 2018

Aquisição centralizada SPMS - P259-2018-99 - Bevacizumab, Pertuzumab, Rituximab e Trastuzumab

Contract value
€1,775,734.91
Signed on
28 August 2018
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 4889134

PUBLISHED SUBJECT

P259-2018-99 - Aquisição de medicamentos ao abrigo do Acordo Quadro 2015/7, 2017/6 e 2017/61 para Instituições do SNS

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Porto, Porto
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
ROCHE FARMACEUTICA QUIMICA, LDA · Tax ID 500233810
Bidder
Bristol-Myers Squibb · Tax ID 500048193
Bidder
Pierre Fabre Lda · Tax ID 500230366

HOW MUCH AND WHEN

Values and timeline

Contract price
€1,775,734.91
Procedure base price
€3,544,155.73
Total effective price
Not reported on Portal BASE
Publication date
19 October 2018
Award date
23 August 2018
Signing date
28 August 2018
Performance period
123 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Not stated
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
CP 2017/6 - Acordo Quadro para fornecimento de Medicamentos do Foro Oncológico e Imunomoduladores, às Instituições e Serviços do Serviço Nacional de Saúde
Centralised procedure
Yes
Environmental criterion
No
Notice
Not stated
Procedure identifier
3513405

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts